1-methyl-4-(2-methanesulfonyloxyethyl)-1H-pyrazole | 176661-71-5

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 有机磺酸及其衍生物
• 英文名称: 1-methyl-4-(2-methanesulfonyloxyethyl)-1H-pyrazole
• 英文别名: 2-(1-methyl-1H-pyrazol-4-yl)-1-mesyloxyethane；1-methyl-4-(2-methanesulfonyloxy)ethyl-1H-pyrazole；1-methyl-4-(2-methanesulfonyloxyethyl)pyrazole；2-(1-methylpyrazol-4-yl)ethyl methanesulfonate
• CAS: 176661-71-5
• 化学式: C₇H₁₂N₂O₃S
• 分子量: 204.25
• InChiKey: PEYYMTMQHLUFHR-UHFFFAOYSA-N

物化性质

• 沸点：
  399.1±25.0 °C(Predicted)
• 密度：
  1.29±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  -0.1
• 重原子数：
  13
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.57
• 拓扑面积：
  69.6
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  1-methyl-4-(2-methanesulfonyloxyethyl)-1H-pyrazole 、 5-氟-3-(4-哌啶)-吲哚 生成 5-fluoro-3-<1-<2-<1-methyl-1H-pyrazol-4-yl>ethyl>-4-piperidinyl>-1H-indole hydrochloride
  参考文献：
  名称：

  5-HT.sub.1F agonists for the treatment of migraine

  摘要：

  这项发明提供了一种新型的5-HT.sub.1F激动剂，可用于治疗偏头痛及相关疾病。

  公开号：

  US05521196A1

文献信息

• Use of serotonin 5-HT1F agonists for the prevention of migraine
  申请人：ELI LILLY AND COMPANY

  公开号：EP0832650A3

  公开（公告）日：1998-09-02

  This invention provides methods for the prevention of migraine which comprises administering to a mammal in need thereof a serotonin 5-HT1F agonist.

  这项发明提供了预防偏头痛的方法，包括向需要的哺乳动物施用一种5-HT1F受体激动剂。
• Use of a serotonin 5-HTlf agonist in the manufacture of a medicament for treating or ameliorating the symptoms of common cold or allergic rhinitis
  申请人：ELI LILLY AND COMPANY

  公开号：EP0824917A3

  公开（公告）日：2000-08-30

  This invention provides methods for the treatment or amelioration of the symptoms of the common cold or allergic rhinitis which comprises administering to a mammal in need thereof a serotonin 5-HT1F agonist.

  这项发明提供了治疗或缓解普通感冒或过敏性鼻炎症状的方法，包括向需要的哺乳动物施用一种5-HT1F受体激动剂。
• Methods of treating or ameliorating the symptoms of common cold or
  申请人：Eli Lilly and Company

  公开号：US05962473A1

  公开（公告）日：1999-10-05

  This invention provides methods for the treatment or amelioration of the symptoms of the common cold or allergic rhinitis which comprises administering to a mammal in need thereof a serotonin 5-HT.sub.1F agonist.

  这项发明提供了治疗或改善普通感冒或过敏性鼻炎症状的方法，包括向需要的哺乳动物施用一种5-羟色胺5-HT.sub.1F激动剂。
• HYDROXAMATE-BASED INHIBITORS OF DEACETYLASES B
  申请人：SHULTZ Michael

  公开号：US20090247547A1

  公开（公告）日：2009-10-01

  The present teachings relate to compounds of Formula I: and pharmaceutically acceptable salts, hydrates, esters, and prodrugs thereof, wherein R 1 , R 2 , R 3 , Y, Z, and are as defined herein. The present teachings also provide methods of preparing compounds of Formula I and methods of using compounds of Formula I in treating, inhibiting, or preventing pathologic conditions or disorders mediated wholly or in part by deacetylases.

  目前的教导与化合物I的公式有关：及其药用盐、水合物、酯和前药，其中R1、R2、R3、Y、Z和如本文所定义的。目前的教导还提供了制备公式I化合物的方法以及使用公式I化合物治疗、抑制或预防完全或部分由去乙酰酶介导的病理状况或紊乱的方法。
• 6-substituted-1,2,3,4-tetrahydro-9H-carbazoles and
  申请人：Eli Lilly and Company

  公开号：US05708187A1

  公开（公告）日：1998-01-13

  This invention provides novel 6-substituted-1,2,3,4-tetrahydro-9H-carbazoles and 7-substituted-10H-cyclohepta\x9b7,6-b!indoles. These compounds are 5-HT.sub.1F agonists which are useful for the treatment of migraine and associated disorders.

  这项发明提供了新颖的6-取代-1,2,3,4-四氢-9H-咔唑和7-取代-10H-环庚\x9b7,6-b!吲哚。这些化合物是5-HT.sub.1F激动剂，对治疗偏头痛及相关疾病有用。